Compare, Analyse Biocon Ltd with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ACTAVIS (US) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ACTAVIS
EQUITY SHARE DATA
    BIOCON
Mar-18
ACTAVIS
Dec-18
BIOCON /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,18813,729-   
Low Rs3059,209-   
Sales per share (Unadj.) Rs68.73,367.7-  
Earnings per share (Unadj.) Rs7.6-1,084.7-  
Cash flow per share (Unadj.) Rs14.0354.9-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.313,890.1-  
Shares outstanding (eoy) m600.00332.60-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.93.4 319.0%   
Avg P/E ratio x98.9-10.6 -934.9%  
P/CF ratio (eoy) x53.432.3 165.3%  
Price / Book Value ratio x8.60.8 1,047.0%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,9003,814,612 11.7%   
No. of employees `0006.116.9 36.4%   
Total wages/salary Rs m9,3110-   
Avg. sales/employee Rs Th6,705.866,277.4 10.1%   
Avg. wages/employee Rs Th1,514.20-   
Avg. net profit/employee Rs Th736.9-21,348.0 -3.5%   
INCOME DATA
Net Sales Rs m41,2341,120,088 3.7%  
Other income Rs m2,06221,420 9.6%   
Total revenues Rs m43,2961,141,507 3.8%   
Gross profit Rs m8,29129,352 28.2%  
Depreciation Rs m3,851478,813 0.8%   
Interest Rs m61564,635 1.0%   
Profit before tax Rs m5,887-492,677 -1.2%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m1,569-6,244 -25.1%   
Profit after tax Rs m4,531-360,781 -1.3%  
Gross profit margin %20.12.6 767.3%  
Effective tax rate %26.71.3 2,103.1%   
Net profit margin %11.0-32.2 -34.1%  
BALANCE SHEET DATA
Current assets Rs m41,486459,401 9.0%   
Current liabilities Rs m21,413406,402 5.3%   
Net working cap to sales %48.74.7 1,028.8%  
Current ratio x1.91.1 171.4%  
Inventory Days Days6420 326.6%  
Debtors Days Days9466 142.0%  
Net fixed assets Rs m50,661126,788 40.0%   
Share capital Rs m3,0000-   
"Free" reserves Rs m48,8080-   
Net worth Rs m51,8084,619,838 1.1%   
Long term debt Rs m17,8981,626,813 1.1%   
Total assets Rs m99,8977,221,859 1.4%  
Interest coverage x10.6-6.6 -159.6%   
Debt to equity ratio x0.30.4 98.1%  
Sales to assets ratio x0.40.2 266.1%   
Return on assets %5.2-4.1 -125.6%  
Return on equity %8.7-7.8 -112.0%  
Return on capital %9.6-4.8 -199.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,7100-   
CASH FLOW
From Operations Rs m6,621400,165 1.7%  
From Investments Rs m-6,840219,839 -3.1%  
From Financial Activity Rs m-2,397-686,803 0.3%  
Net Cashflow Rs m-2,612-66,466 3.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: WOCKHARDT  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFESCIENCES  ALKEM LABORATORIES  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Oct 23, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS